Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,000.00
Bid: 1,980.00
Ask: 2,000.00
Change: 10.00 (0.51%)
Spread: 20.00 (1.01%)
Open: 1,965.00
High: 2,000.00
Low: 1,965.00
Prev. Close: 1,980.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and Total Voting Rights

6 Oct 2017 17:50

RNS Number : 9954S
S & U PLC
06 October 2017
 

 S & U PLC ("S&U" or "the Company")

Exercise and Sale of Options, Director/PDMR Shareholding and Total Voting Rights

6 October 2017

 

 

Exercise and Sale of Options

 

S&U plc announces that it has today received notice of the exercise in respect of options granted to Mr John Guy Thompson, a director of S&U plc; 2,500 options under the Company's 2010 Long Term Incentive Plan ("LTIP") were exercised at an exercise price of 12.5 pence per share and 450 options under the Company's 2008 Discretionary Share Option Plan ("DSOP") were exercised at an exercise price of 1,892.5 pence per share. These notices for Mr John Guy Thompson were in respect of a total of 2,950 ordinary shares of 12.5p each ("Ordinary Shares") and these 2,950 Ordinary Shares were sold in the market at an average price of 2,055.83 pence per share. Following these transactions the shareholding of Mr John Guy Thompson is nil.

 

S&U plc has also received due notice of exercise in respect of options granted to members of its senior management under the Company's 2010 Long Term Incentive Plan ("LTIP"). The notices were in respect of a total of 6,000 ordinary shares of 12.5p each ("Ordinary Shares") at the exercise price of 12.5 pence per share. 3,500 of these Ordinary Shares were sold in the market at a price of 2,074 pence per share and 2,500 Ordinary Shares were retained by senior management.

 

In total, 8,950 Ordinary Shares were admitted to trading this week pursuant to an existing block listing, and will rank pari pasu with existing Ordinary Shares.

 

Total Voting Rights

 

Following the issue of these Ordinary Shares, the total number of voting rights in S&U is 11,985,659. This number (11,985,659) should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of S&U under the FCA's Disclosure and Transparency rules.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

John Guy Thompson

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

S&U PLC

b)

 

LEI

 

 

213800QZ1X2A7J64SQ31

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 12.5p each

 

 

ISIN : GB0007655037

 

b)

 

Nature of the transaction

 

 

Exercise of options under the Company's 2010 Long Term Incentive and 2008 Discretionary Share Option Plans.

c)

 

Price(s) and volume(s)

 

 

 

Exercise Price(s)

 

Volume(s)

12.5p

2,500

1,892.5p

450

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

N/A

 

 

 

 

e)

 

Date of the transaction

 

 

6th October 2017

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 12.5p each

 

 

ISIN : GB0007655037

 

b)

 

Nature of the transaction

 

 

Sale of Ordinary Shares following an exercise of options under the Company's 2010 Long Term Incentive and 2008 Discretionary Share Option Plans.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

2,067.19p

1,000

 

2,050p

1,950

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

Aggregated volume: 2,950

Volume weighted average price: 2,055.83p

 

 

 

e)

 

Date of the transaction

 

 

6th October 2017

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

For further information, please contact: 

Anthony Coombs, Chairman S&U plc (www.suplc.co.uk) 0121 705 7777

 

Broker and Financial Adviser

Adrian Trimmings/Rishi Shah Peel Hunt 0207 418 8900

 

Media and Investor Relations

Ged Brumby Smithfield 0207 360 4900 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAKEKELNXFFF
Date   Source Headline
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.